Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH

Visit https://www.peervoice.com/NBF860 to view the entire programme with slides. After completing “Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH”, participants will be able to: Explain the rationale for prompt identification and active management of individuals with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, based on the increased risk of adverse liver outcomes associated with progression of fibrosis; Recall the mechanistic and evidence-based rationale for THR-β agonists as disease-specific pharmacotherapy for management of individuals with MASH and fibrosis; and Identify practical steps to improve the implementation of timely, comprehensive management strategies for MASH that integrate liver-directed therapies, lifestyle modifications, and comorbidity management.

Listen